| Literature DB >> 29636391 |
Oluseye A Ogunbayo1, Jingxian Duan1, Jian Xiong2, Qiaochu Wang2, Xinghua Feng2, Jianjie Ma3, Michael X Zhu2, A Mark Evans4.
1. Centres for Discovery Brain Sciences and Cardiovascular Sciences, Biomedical Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9XD Scotland, UK.
2. Department of Integrative Biology and Pharmacology, McGovern Medical School, Program in Biochemistry and Cell Biology, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
3. Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
4. Centres for Discovery Brain Sciences and Cardiovascular Sciences, Biomedical Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9XD Scotland, UK. mark.evans@ed.ac.uk.
Abstract
Entities:
Mesh:
Animals
Calcium/metabolism
Calcium Channels/genetics
Calcium Channels/metabolism
Cells, Cultured
HEK293 Cells
Humans
Lysosomes/drug effects
Lysosomes/metabolism
Male
Mechanistic Target of Rapamycin Complex 1/antagonists & inhibitors
Mechanistic Target of Rapamycin Complex 1/metabolism
Mice, Inbred C57BL
Mice, Knockout
Myocytes, Smooth Muscle/drug effects
Myocytes, Smooth Muscle/metabolism
NADP/analogs & derivatives
NADP/pharmacology
Pulmonary Artery/cytology
Rats, Wistar
Signal Transduction/drug effects
Sirolimus/pharmacology
Substances:
Calcium Channels
NADP
NAADP
Mechanistic Target of Rapamycin Complex 1
Calcium
Sirolimus
Year: 2018 PMID: 29636391 PMCID: PMC6055479 DOI: 10.1126/scisignal.aao5775
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192